Cito Capital Group, LLC Sangamo Therapeutics, Inc Transaction History

Cito Capital Group, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$5.23 - $7.82 $230,120 - $344,080	-44,000 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$7.29 - $10.97 $109,350 - $164,550	-15,000 Reduced 25.42%	44,000 $330,000
Q3 2021 Nov 10, 2021	SELL	$9.01 - $12.01 $72,080 - $96,080	-8,000 Reduced 11.94%	59,000 $532,000
Q2 2021 Aug 16, 2021	SELL	$10.17 - $12.64 $71,190 - $88,480	-7,000 Reduced 9.46%	67,000 $802,000
Q1 2021 May 17, 2021	SELL	$10.88 - $17.05 $65,280 - $102,300	-6,000 Reduced 7.5%	74,000 $927,000
Q4 2020 Feb 16, 2021	SELL	$9.23 - $18.18 $32,305 - $63,630	-3,500 Reduced 4.19%	80,000 $1.25 Million
Q2 2020 Aug 11, 2020	BUY	$6.21 - $11.83 $208,035 - $396,305	33,500 Added 67.0%	83,500 $748,000
Q1 2020 May 15, 2020	BUY	$5.05 - $8.85 $60,600 - $106,200	12,000 Added 31.58%	50,000 $319,000
Q2 2019 Aug 14, 2019	SELL	$8.75 - $13.03 $26,250 - $39,090	-3,000 Reduced 7.32%	38,000 $409,000
Q1 2019 May 13, 2019	SELL	$7.72 - $12.81 $92,640 - $153,720	-12,000 Reduced 22.64%	41,000 $391,000
Q3 2018 Nov 13, 2018	BUY	$13.05 - $19.05 $13,050 - $19,050	1,000 Added 1.92%	53,000 $898,000
Q2 2018 Jul 03, 2018	BUY	$13.9 - $19.8 $83,400 - $118,800	6,000 Added 13.04%	52,000 $738,000
Q1 2018 May 14, 2018	BUY	$16.7 - $26.35 $768,200 - $1.21 Million	46,000 New	46,000 $0

114

56.3M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $321M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Cito Capital Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Cito Capital Group, LLC with notifications on news.